These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1326801)

  • 1. Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein.
    Chen HF; Kevan-Jah S; Suentzenich KO; Grässer FA; Mueller-Lantzsch N
    Virology; 1992 Sep; 190(1):106-15. PubMed ID: 1326801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Epstein-Barr virus membrane antigen gp350/220 in E. coli and in insect cells.
    Nuebling CM; Buck M; Boos H; von Deimling A; Mueller-Lantzsch N
    Virology; 1992 Nov; 191(1):443-7. PubMed ID: 1329330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
    Rowe M; Finke J; Szigeti R; Klein G
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases.
    Xu J; Ahmad A; D'Addario M; Knafo L; Jones JF; Prasad U; Dolcetti R; Vaccher E; Menezes J
    J Immunol; 2000 Mar; 164(5):2815-22. PubMed ID: 10679125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP).
    Sulitzeanu D; Szigeti R; Hatzubai A; Dillner J; Hammarskjöld ML; Klein G; Klein E
    Immunol Lett; 1988 Aug; 18(4):301-6. PubMed ID: 2846438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS
    Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B.
    Geertsen R; Espander-Jansson A; Dobec M; Price P; Wunderli W; Rymo L
    J Clin Microbiol; 1994 Jan; 32(1):112-20. PubMed ID: 8126164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein.
    Bryden H; MacKenzie J; Andrew L; Alexander FE; Angus B; Krajewski AS; Armstrong AA; Gray D; Cartwright RA; Kane E; Wright DH; Taylor P; Jarrett RF
    Int J Cancer; 1997 Aug; 72(4):614-8. PubMed ID: 9259400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS; Dawson CW; Clark D; Rupani H; Busson P; Tursz T; Johnson A; Rickinson AB
    J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis.
    Isaacson PG; Schmid C; Pan L; Wotherspoon AC; Wright DH
    J Pathol; 1992 Jul; 167(3):267-71. PubMed ID: 1381432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.